Sodium stearyl fumarate improves flowability, compressibility, homogeneity, and dissolution in a film-coated empagliflozin-metformin tablet.
A biocompatible polymer coating lets oral CO2 absorbents lower body carbon dioxide without the toxicity of caustic in vivo scrubbers.
By targeting both renin-angiotensin and chemokine pathways, this combination therapy reduces monocyte-driven inflammation and kidney fibrosis.
Combining vanzacaftor with additional CFTR modulators improves F508del trafficking, cell-surface stability, and ion transport.
Dual blockade of angiotensin and CCR2 signaling improves renal function and reduces kidney damage markers when monotherapy falls short.
Phase inversion creates high-drug-load biodegradable implants that sustain antiretroviral release for months and reduce daily adherence burden.
A direct-compression dispersible tablet balances rapid disintegration with low moisture exposure for stable, palatable lisdexamfetamine delivery.
A multi-unit Rooibos extract composition combines immediate and sustained release to overcome rapid elimination and maintain polyphenol delivery for hours.
A two-stage granulation tablet composition balances high hardness with ultra-fast oral disintegration without freeze-drying.
Fine potassium chloride crystals coated with up to 9% cellulosic polymer improve sustained release, content uniformity, and manufacturing efficiency.
Physical separation of sacubitril-valsartan and an SGLT-2 inhibitor preserves dissolution, limits impurities, and improves stability.
A low-dose ARB, diuretic, and calcium channel blocker combination improves blood pressure control while limiting side effects and tolerability issues.